Contents

Search

Buprenorphine Implant (Probuphine)

FDA-approved May 2016. [2] Dosage: - subdermal implant of 6 months duration - four inch-long rods placed subdermally on the inside of the upper arm [2]

Interactions

drug adverse effects of opiates

General

buprenorphine (Buprenex, Subutex, Temgesic, Sublocade, Butrans 'professional man's methadone') drug delivery implant

References

  1. Young K, Sadoughi S, Saitz R Buprenorphine Implant for Opioid Addiction Recommended for Approval. Physician's First Watch, Jan 14, 2016 David G. Fairchild, MD, MPH, Editor-in-Chief Massachusetts Medical Society http://www.jwatch.org
  2. Young K, Sofair A, Chavey WE. FDA Approves Implant to Treat Opioid Dependence. Physician's First Watch, May 27, 2016 David G. Fairchild, MD, MPH, Editor-in-Chief Massachusetts Medical Society http://www.jwatch.org - FDA News Release. May 26, 2016 FDA approves first buprenorphine implant for treatment of opioid dependence. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm503719.htm